Suppr超能文献

卡托普利用于慢性肾衰竭和肾移植患者的顽固性高血压

Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.

作者信息

Hamilton D V, Evans D B, Maidment G, Pryor J S

出版信息

J R Soc Med. 1981 May;74(5):357-62.

Abstract

The converting-enzyme inhibitor, captopril, was given to ten patients with refractory severe hypertension of renal origin: 6 patients had chronic renal failure, 3 patients had hypertension following renal transplantation, and one patient had hypertension and congestive cardiac failure. Control of blood pressure was achieved with doses from 78 to 400 mg/day. Severe hyperkalaemia occurred in one patients, ageusia (dose dependent) in another, and one patients withdrew from treatment because of nausea.

摘要

给10例顽固性肾源性重度高血压患者服用转换酶抑制剂卡托普利:6例患有慢性肾衰竭,3例在肾移植后出现高血压,1例患有高血压和充血性心力衰竭。通过每日78至400毫克的剂量实现了血压控制。1例患者出现严重高钾血症,另1例出现味觉丧失(剂量依赖性),1例患者因恶心退出治疗。

相似文献

7
Captopril in hypertension after renal transplantation.卡托普利用于肾移植术后高血压
Postgrad Med J. 1984 Feb;60(700):132-4. doi: 10.1136/pgmj.60.700.132.

本文引用的文献

9
Bilateral nephrectomy prior to renal transplantation.肾移植前双侧肾切除术。
Br J Surg. 1976 Jul;63(7):512-6. doi: 10.1002/bjs.1800630704.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验